These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

74 related articles for article (PubMed ID: 3023251)

  • 1. The lack of effects of alkylating agents on mammalian cell membranes.
    Ankel EG; Ring BJ; Lai CS; Holcenberg JS
    Int J Tissue React; 1986; 8(5):347-54. PubMed ID: 3023251
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Interaction of the alkylating antitumor agent 2,3,5-tris(ethyleneimino)benzoquinone with the plasma membrane of Ehrlich ascites tumor cells.
    Ihlenfeldt M; Gantner G; Harrer M; Puschendorf B; Putzer H; Grunicke H
    Cancer Res; 1981 Jan; 41(1):289-93. PubMed ID: 6256062
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The role of drug transport in resistance to nitrogen mustard and other alkylating agents in L518Y lymphoblsts.
    Goldenberg GJ
    Cancer Res; 1975 Jul; 35(7):1687-92. PubMed ID: 1055634
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Different inhibitory effect of nitrogen mustard (HN2) and TS-160 (HN3) on choline transport in L 5178Y lymphoblasts.
    Ujházy V; Kolarov J; Kuzela S; Krempaský V; Bohunická E
    Neoplasma; 1975; 22(6):621-3. PubMed ID: 1240604
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Differential enhancement of antitumor effectiveness by phospholipid vesicles (liposomes).
    Ritter C; Iyengar CL; Rutman RJ
    Cancer Res; 1981 Jun; 41(6):2366-71. PubMed ID: 7237434
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Depression of histone acetylation by alkylating antitumor agents in murine cells.
    Zwierzina H; Loidl A; Fuith LC; Helliger W; Puschendorf B; Grunicke H
    Cancer Res; 1984 Aug; 44(8):3336-9. PubMed ID: 6744267
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Modulation of the cellular toxicity of nitrogen mustard in murine cells.
    Ritter C; Rutman RJ; Goldstein NO
    Cancer Res; 1987 Jan; 47(2):472-6. PubMed ID: 3791235
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Reactions of the alkylating agent tris(2-chloroethyl)-amine with the erythrocyte membrane. Effects on shape changes of human erythrocytes and ghosts.
    Wildenauer DB; Reuther H; Remien J
    Biochim Biophys Acta; 1980 Dec; 603(1):101-16. PubMed ID: 7448181
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Doxorubicin (Adriamycin) transport in Ehrlich ascites tumour cells: comparison with transport in human red blood cells.
    Dalmark M; Hoffmann EK
    Scand J Clin Lab Invest; 1983 May; 43(3):241-8. PubMed ID: 6312556
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Complex effects of sulfhydryl reagents on ligand interactions with nucleoside transporters: evidence for multiple populations of ENT1 transporters with differential sensitivities to N-ethylmaleimide.
    Vyas S; Ahmadi B; Hammond JR
    Arch Biochem Biophys; 2002 Jul; 403(1):92-102. PubMed ID: 12061806
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Influence of some DNA-alkylating drugs on thermal stability, acid and osmotic resistance of the membrane of whole human erythrocytes and their ghosts.
    Ivanov IT; Gadjeva V
    Pharmazie; 2000 Sep; 55(9):672-7. PubMed ID: 11031771
    [TBL] [Abstract][Full Text] [Related]  

  • 12. EPR spectroscopic analysis of binding sites of a cancerostatic agent on erythrocyte membranes.
    Lassmann G; Herrmann A; Raikov Z; Müller P
    Cancer Biochem Biophys; 1987 May; 9(2):169-78. PubMed ID: 3040220
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Overexpression of GSTA2 protects against cell cycle arrest and apoptosis induced by the DNA inter-strand crosslinking nitrogen mustard, mechlorethamine.
    Xie J; Shults K; Flye L; Jiang F; Head DR; Briggs RC
    J Cell Biochem; 2005 May; 95(2):339-51. PubMed ID: 15778998
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibition of tumor growth by an alkylation of the plasma membrane.
    Grunicke H; Grünewald K; Helliger W; Scheidl F; Wolff-Schreiner E; Puschendorf B
    Adv Enzyme Regul; 1983; 21():21-30. PubMed ID: 6100583
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The contribution of alkylation to the activity of quinone antitumor agents.
    Begleiter A
    Can J Physiol Pharmacol; 1986 May; 64(5):581-5. PubMed ID: 3730943
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cytoskeleton vimentin disruption of mouse sertoli cells injured by nitrogen mustard in vitro.
    He D; Zhang D; Wei G; Lin T; Li X
    J Androl; 2007; 28(3):389-96. PubMed ID: 17192600
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Low-molecular weight inhibitory factor released in vitro by murine L5178Y leukemic cells.
    Chmurzyńska W; Grzelakowska-Sztabert B
    Neoplasma; 1987; 34(5):513-21. PubMed ID: 2447509
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification of membrane proteins related to anion transport in Ehrlich ascites tumor cells.
    Hoffmann EK; Sjøholm C; Uerkvitz W
    Tokai J Exp Clin Med; 1982; 7 Suppl():103-11. PubMed ID: 7186216
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bifunctional alkylating agent-induced p53 and nonclassical nuclear factor kappaB responses and cell death are altered by caffeic acid phenethyl ester: a potential role for antioxidant/electrophilic response-element signaling.
    Minsavage GD; Dillman JF
    J Pharmacol Exp Ther; 2007 Apr; 321(1):202-12. PubMed ID: 17204746
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Preclinical studies and clinical correlation of the effect of alkylating dose.
    Frei E; Teicher BA; Holden SA; Cathcart KN; Wang YY
    Cancer Res; 1988 Nov; 48(22):6417-23. PubMed ID: 3180059
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.